Billy Lipschultz
PersonHeard in 2 episodes across 1 show since Jun 2026
Billy Lipschultz is a market commentator and guest on Bloomberg. He has appeared on Bloomberg Radio with hosts Carol Massar and Paul Sweeney to discuss day-to-day market-moving stocks.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 1 |
| Jul 2026 | 1 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
What Billy Lipschultz has said on podcasts
16 statements
Vertex Pharmaceuticals agreed to acquire Kinetics Pharma for $85 per share.
“Vertex Pharmaceuticals agreeing to acquire kinetics Pharma for 85 bucks a share.”
Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf JumpsListen at 1:07
The Vertex-Kinetics deal has approximately $10 billion equity value, or $8.8 billion net of cash.
“the driver for that total equity value, about $10 billion, 8.8 billion net of estimated cash.”
Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf JumpsListen at 1:25
Vertex had a $134 billion market capitalization before the deal.
“$134 billion market cap prior to this deal.”
Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf JumpsListen at 1:48
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
2 episodes featuring Billy Lipschultz, newest first
